Weixin Chen

发表

Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19

Qin Li, Wei Zhao, Qun Zheng, 2022, mBio.

Heterologous prime-boost regimens with HAdV-5 and NDV vectors elicit stronger immune responses to Ebola virus than homologous regimens in mice

Wei Zhao, Qingzhong Yu, Jiang Wu, 2021, Archives of Virology.

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals

Jiang Wu, Juan Li, Weixin Chen, 2021, Human vaccines & immunotherapeutics.

A cross-sectional study of alcohol consumption and alcoholic liver disease in Beijing: based on 74,998 community residents

Huai Wang, M. Lv, P. Gao, 2022, BMC Public Health.

Changing epidemiological characteristics of Hepatitis A and warning of Anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017

Huai Wang, X. Pang, Jiang Wu, 2018, Human vaccines & immunotherapeutics.

Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China

Huai Wang, M. Lv, P. Gao, 2022, International journal of environmental research and public health.

Hepatitis B infection in the general population of China: a systematic review and meta-analysis

Huai Wang, Jiang Wu, Y. Xiao, 2019, BMC Infectious Diseases.

Immune Persistence against SARS-CoV-2 after Primary and Booster Immunization in Humans: A Large-Scale Prospective Cohort Study

Quanyi Wang, X. Pang, Chun Huang, 2022, Vaccines.

Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization

Shanshan Zhou, Xiaojing Wen, Juan Li, 2022, International Journal of Infectious Diseases.

Exploration of a new hepatitis a surveillance system in Beijing, China: based on molecular epidemiology

Huai Wang, Jing-yuan Cao, Wen-jiao Yin, 2022, BMC Infectious Diseases.

Molecular surveillance of rubella virus in Beijing, China during 2010-2021: Progress and challenges in rubella elimination.

Meng Chen, Xiaoqun Mu, L. Suo, 2022, Vaccine.

The kinetics of IgG subclasses and contributions to neutralizing activity against SARS‐CoV‐2 wild‐type strain and variants in healthy adults immunized with inactivated vaccine

Bing Zhang, Qun Zheng, Juan Li, 2022, Immunology.

Comparison of Immunogenicity of Alum and MF59-Like Adjuvant Inactivated SARS-CoV-2 Vaccines Against SARS-CoV-2 Variants in Elderly Mice.

Jian Wang, Wei Zhao, M. Lv, 2023, Viral immunology.

Baseline Pneumococcal IgG Levels and Response to 23-Valent Pneumococcal Polysaccharide Vaccine among Adults from Beijing, China

Jian Wang, M. Lv, Weixin Chen, 2023, Vaccines.

Immunogenicity and safety of different combinations involving a third booster dose of SARS-CoV-2 inactivated vaccine, inactivated quadrivalent influenza vaccine, and 23-valent pneumococcal polysaccharide vaccine in adults aged ≥60 years: a phase 4, randomized, open-label study

Jian Wang, M. Lv, Weixin Chen, 2024, Frontiers in immunology.